Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A new cognitive evaluation battery for Down syndrome and its relevance for clinical trials.
de Sola S, de la Torre R, Sánchez-Benavides G, Benejam B, Cuenca-Royo A, Del Hoyo L, Rodríguez J, Catuara-Solarz S, Sanchez-Gutierrez J, Dueñas-Espin I, Hernandez G, Peña-Casanova J, Langohr K, Videla S, Blehaut H, Farre M, Dierssen M; TESDAD Study Group. de Sola S, et al. Among authors: benejam b. Front Psychol. 2015 Jun 4;6:708. doi: 10.3389/fpsyg.2015.00708. eCollection 2015. Front Psychol. 2015. PMID: 26089807 Free PMC article.
Epigallocatechin-3-gallate, a DYRK1A inhibitor, rescues cognitive deficits in Down syndrome mouse models and in humans.
De la Torre R, De Sola S, Pons M, Duchon A, de Lagran MM, Farré M, Fitó M, Benejam B, Langohr K, Rodriguez J, Pujadas M, Bizot JC, Cuenca A, Janel N, Catuara S, Covas MI, Blehaut H, Herault Y, Delabar JM, Dierssen M. De la Torre R, et al. Among authors: benejam b. Mol Nutr Food Res. 2014 Feb;58(2):278-88. doi: 10.1002/mnfr.201300325. Epub 2013 Sep 14. Mol Nutr Food Res. 2014. PMID: 24039182 Clinical Trial.
Periodontal disease's contribution to Alzheimer's disease progression in Down syndrome.
Kamer AR, Fortea JO, Videla S, Mayoral A, Janal M, Carmona-Iragui M, Benejam B, Craig RG, Saxena D, Corby P, Glodzik L, Annam KR, Robbins M, de Leon MJ. Kamer AR, et al. Among authors: benejam b. Alzheimers Dement (Amst). 2016 Feb 4;2:49-57. doi: 10.1016/j.dadm.2016.01.001. eCollection 2016. Alzheimers Dement (Amst). 2016. PMID: 27239536 Free PMC article. Review.
Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 trial.
de la Torre R, de Sola S, Hernandez G, Farré M, Pujol J, Rodriguez J, Espadaler JM, Langohr K, Cuenca-Royo A, Principe A, Xicota L, Janel N, Catuara-Solarz S, Sanchez-Benavides G, Bléhaut H, Dueñas-Espín I, Del Hoyo L, Benejam B, Blanco-Hinojo L, Videla S, Fitó M, Delabar JM, Dierssen M; TESDAD study group. de la Torre R, et al. Among authors: benejam b. Lancet Neurol. 2016 Jul;15(8):801-810. doi: 10.1016/S1474-4422(16)30034-5. Lancet Neurol. 2016. PMID: 27302362 Clinical Trial.
Cross-sectional versus longitudinal cognitive assessments for the diagnosis of symptomatic Alzheimer's disease in adults with Down syndrome.
Videla L, Benejam B, Carmona-Iragui M, Barroeta I, Fernández S, Arranz J, Azzahchi SE, Altuna M, Padilla C, Valldeneu S, Pegueroles J, Montal V, Aranha MR, Vaqué-Alcázar L, Iulita MF, Alcolea D, Bejanin A, Videla S, Blesa R, Lleó A, Fortea J. Videla L, et al. Among authors: benejam b. Alzheimers Dement. 2023 Sep;19(9):3916-3925. doi: 10.1002/alz.13073. Epub 2023 Apr 11. Alzheimers Dement. 2023. PMID: 37038748
Diagnosis of prodromal and Alzheimer's disease dementia in adults with Down syndrome using neuropsychological tests.
Benejam B, Videla L, Vilaplana E, Barroeta I, Carmona-Iragui M, Altuna M, Valldeneu S, Fernandez S, Giménez S, Iulita F, Garzón D, Bejanin A, Bartrés-Faz D, Videla S, Alcolea D, Blesa R, Lleó A, Fortea J. Benejam B, et al. Alzheimers Dement (Amst). 2020 Jun 28;12(1):e12047. doi: 10.1002/dad2.12047. eCollection 2020. Alzheimers Dement (Amst). 2020. PMID: 32613076 Free PMC article.
Evaluation of biochemical and hematological parameters in adults with Down syndrome.
de Gonzalo-Calvo D, Barroeta I, Nan MN, Rives J, Garzón D, Carmona-Iragui M, Benejam B, Videla L, Fernández S, Altuna M, Valldeneu S, Blesa R, Lleó A, Blanco-Vaca F, Fortea J, Tondo M. de Gonzalo-Calvo D, et al. Among authors: benejam b. Sci Rep. 2020 Aug 13;10(1):13755. doi: 10.1038/s41598-020-70719-2. Sci Rep. 2020. PMID: 32792619 Free PMC article.
Feasibility and Long-Term Compliance to Continuous Positive Airway Pressure Treatment in Adults With Down Syndrome, a Genetic Form of Alzheimer's Disease.
Giménez S, Farre A, Morente F, Videla L, Gutiérrez M, Clos S, Fernández A, Blanco M, Altuna M, Pegueroles J, Asensio A, Benejam B, Batista M, Barroeta I, Fortuna A, Fortea J, Mayos M. Giménez S, et al. Among authors: benejam b. Front Neurosci. 2022 Mar 30;16:838412. doi: 10.3389/fnins.2022.838412. eCollection 2022. Front Neurosci. 2022. PMID: 35431793 Free PMC article.
Longitudinal Clinical and Cognitive Changes Along the Alzheimer Disease Continuum in Down Syndrome.
Videla L, Benejam B, Pegueroles J, Carmona-Iragui M, Padilla C, Fernández S, Barroeta I, Altuna M, Valldeneu S, Garzón D, Ribas L, Montal V, Arranz Martínez J, Rozalem Aranha M, Alcolea D, Bejanin A, Iulita MF, Videla Cés S, Blesa R, Lleó A, Fortea J. Videla L, et al. Among authors: benejam b. JAMA Netw Open. 2022 Aug 1;5(8):e2225573. doi: 10.1001/jamanetworkopen.2022.25573. JAMA Netw Open. 2022. PMID: 35930282 Free PMC article.
48 results